Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP | May 29, 2020 | June 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 29, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 224,478 |
Reported balance
After 2020-05-29 transaction · row 1
1 source rowRow 1 · 2020-05-29 · Grant · Acquired 557 · Balance 224,478 F1: Unvested restricted stock units vest as follows: 278 on May 29, 2021 and 279 on May, 29 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested restricted stock units vest as follows: 278 on May 29, 2021 and 279 on May, 29 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2018 Filed Mar 2, 2018 00:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 646 | $107.82 | $69,651.72 |
DisclosureSEC source: 0001127602-18-009445 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,493 Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 21:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 621 | $108.95 | $67,657.95 |
DisclosureSEC source: 0001127602-18-009067 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,139 Read SEC document |
| February 26, 2018 Filed Feb 26, 2018 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 1,033 | $109.34 | $112,948.22 |
DisclosureSEC source: 0001127602-18-008326 · form4.xml · nonDerivative · entry 4 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,760 Read SEC document |
| February 24, 2018 Filed Feb 26, 2018 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 981 | $109.34 | $107,262.54 |
DisclosureSEC source: 0001127602-18-008326 · form4.xml · nonDerivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,793 Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 26,491 | $0.00 Strike: $109.34 | $0.00 |
DisclosureSEC source: 0001127602-18-008326 · form4.xml · derivative · entry 5 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,491 Underlying: Common Stock · 26,491 shares Expires 2023-02-23 F3 · derivative.exercise_date: Stock options vest as follows: 6,622 options vest one (1) year from the date of grant, 6,623 options vest two (2) years from the date of grant, 6,623 options vest three (3) years from the date of grant, and 6,623 options vest four (4) years from the date of grant. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 5,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-008326 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,774 F2 · security: Consists of 5,869 unvested restricted stock units that vest as follows: 1,467 shares vest one (1) year from the date of issuance, 1,467 shares vest two (2) years from the date of issuance, 1,467 shares vest three (3) years from the date of issuance, and 1,468 shares vest four (4) years from the date of issuance. Read SEC document |
| February 23, 2018 Filed Feb 26, 2018 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 947 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-008326 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,905 F1 · security: Consists of 947 unvested restricted stock units that vest as follows: 473 shares vest one (1) year from the date of grant, and 474 shares vest two (2) years from the date of grant. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 17:13 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 6,901 | $106.97 | $738,199.97 |
DisclosureSEC source: 0001127602-18-002585 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,958 Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 17:13 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 18,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-002585 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,859 F1 · kind: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 27, 2015. Read SEC document |
| October 05, 2017 Filed Oct 6, 2017 16:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 24,759 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001127602-17-029532 · form4.xml · derivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,759 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2017 Filed Oct 6, 2017 16:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 24,759 | $110.00 | $2,723,490.00 |
DisclosureSEC source: 0001127602-17-029532 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,255 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| October 05, 2017 Filed Oct 6, 2017 16:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 24,759 | $40.40 | $1,000,263.60 |
DisclosureSEC source: 0001127602-17-029532 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,800 | $89.56 | $161,208.00 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 13 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,255 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 97 | $89.55 | $8,686.35 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 12 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,055 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $89.53 | $89.53 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 11 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,152 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $89.50 | $89.50 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 10 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,153 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $89.46 | $89.46 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 9 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,154 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $89.43 | $44,715.00 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 8 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,155 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 659 | $89.42 | $58,927.78 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 7 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,655 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 436 | $89.41 | $38,982.76 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 6 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,314 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,200 | $89.40 | $107,280.00 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 5 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,750 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,101 | $89.39 | $98,418.39 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 4 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,950 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,501 | $89.38 | $134,159.38 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 3 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,051 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 9 | $89.37 | $804.33 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 2 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,552 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $89.36 | $89.36 |
DisclosureSEC source: 0001127602-17-011425 · form4.xml · nonDerivative · entry 1 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,561 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 22,150 | $0.00 Strike: $36.25 | $0.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · derivative · entry 32 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,150 shares Expires 2019-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 19,750 | $0.00 Strike: $37.03 | $0.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · derivative · entry 31 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,750 shares Expires 2018-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $89.34 | $8,934.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 30 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,562 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $89.33 | $35,732.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 29 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,662 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $89.32 | $89.32 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 28 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,062 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $89.31 | $89.31 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 27 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,063 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 301 | $89.30 | $26,879.30 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 26 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,064 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 285 | $89.29 | $25,447.65 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 25 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,365 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 950 | $89.28 | $84,816.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 24 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,650 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $89.26 | $89.26 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 23 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,600 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 301 | $89.25 | $26,864.25 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 22 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,601 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 310 | $89.24 | $27,664.40 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 21 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,902 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $89.23 | $8,923.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 20 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,212 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 800 | $89.22 | $71,376.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 19 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,312 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 275 | $89.21 | $24,532.75 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 18 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,112 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $89.20 | $26,760.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 17 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,387 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,173 | $89.19 | $104,619.87 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 16 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,687 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $89.18 | $35,672.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 15 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,860 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 35 | $89.17 | $3,120.95 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 14 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,260 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $89.15 | $35,660.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 13 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,295 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $89.14 | $26,742.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 12 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,695 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 7 | $89.13 | $623.91 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 11 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,995 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $89.10 | $17,820.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 10 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,002 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 800 | $89.09 | $71,272.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 9 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,202 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,050 | $89.08 | $93,534.00 |
DisclosureSEC source: 0001127602-17-011423 · form4.xml · nonDerivative · entry 8 JOHST DAVID P · CIK 0001144770 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,002 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.